Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 22% ± 7% | |
| goblet cell | 7 studies | 35% ± 24% | |
| epithelial cell | 6 studies | 29% ± 11% | |
| type II pneumocyte | 6 studies | 21% ± 5% | |
| luminal hormone-sensing cell of mammary gland | 4 studies | 34% ± 9% | |
| luminal cell of prostate epithelium | 4 studies | 34% ± 3% | |
| club cell | 4 studies | 22% ± 4% | |
| secretory cell | 3 studies | 26% ± 5% | |
| respiratory goblet cell | 3 studies | 30% ± 7% |
Insufficient scRNA-seq data for expression of RASEF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 96% | 2537.19 | 236 / 245 | 99% | 42.48 | 496 / 502 |
| thymus | 100% | 2990.96 | 652 / 653 | 92% | 34.77 | 555 / 605 |
| pancreas | 100% | 3279.43 | 328 / 328 | 88% | 26.89 | 157 / 178 |
| kidney | 98% | 603.01 | 87 / 89 | 75% | 10.01 | 680 / 901 |
| stomach | 77% | 2079.09 | 278 / 359 | 93% | 24.41 | 267 / 286 |
| lung | 81% | 865.67 | 471 / 578 | 81% | 16.98 | 930 / 1155 |
| breast | 61% | 1479.78 | 281 / 459 | 94% | 42.49 | 1053 / 1118 |
| intestine | 49% | 1068.62 | 469 / 966 | 96% | 26.60 | 507 / 527 |
| bladder | 48% | 560.90 | 10 / 21 | 82% | 15.35 | 415 / 504 |
| esophagus | 40% | 548.65 | 573 / 1445 | 80% | 23.81 | 146 / 183 |
| ureter | 0% | 0 | 0 / 0 | 100% | 20.21 | 1 / 1 |
| uterus | 12% | 63.30 | 21 / 170 | 70% | 12.29 | 320 / 459 |
| skin | 53% | 226.61 | 953 / 1809 | 23% | 3.59 | 110 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 71% | 13.46 | 32 / 45 |
| ovary | 6% | 19.38 | 11 / 180 | 56% | 6.26 | 242 / 430 |
| liver | 20% | 81.59 | 45 / 226 | 33% | 5.03 | 132 / 406 |
| adrenal gland | 3% | 9.01 | 7 / 258 | 45% | 7.35 | 103 / 230 |
| brain | 2% | 5.64 | 47 / 2642 | 7% | 0.73 | 48 / 705 |
| blood vessel | 2% | 10.20 | 26 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 2% | 6.08 | 22 / 1204 | 0% | 0 | 0 / 0 |
| heart | 0% | 1.34 | 4 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.70 | 2 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.60 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0016192 | Biological process | vesicle-mediated transport |
| GO_0005829 | Cellular component | cytosol |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0019003 | Molecular function | GDP binding |
| GO_0005525 | Molecular function | GTP binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | RASEF |
| Protein name | Alternative protein RASEF Ras and EF-hand domain-containing protein (Ras-related protein Rab-45) |
| Synonyms | RAB45 |
| Description | FUNCTION: Binds predominantly GDP, and also GTP . Acts as a dynein adapter protein that activates dynein-mediated transport and dynein-dynactin motility on microtubules . . |
| Accessions | ENST00000340717.4 [Q8IZ41-2] L8ECN1 ENST00000376447.4 [Q8IZ41-1] Q8IZ41 |
